1. Home
  2. BANL vs LSTA Comparison

BANL vs LSTA Comparison

Compare BANL & LSTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

BANL

CBL International Limited

HOLD

Current Price

$0.41

Market Cap

11.7M

Sector

Energy

ML Signal

HOLD

Logo Lisata Therapeutics Inc.

LSTA

Lisata Therapeutics Inc.

HOLD

Current Price

$1.98

Market Cap

20.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BANL
LSTA
Founded
2015
1980
Country
Malaysia
United States
Employees
N/A
N/A
Industry
Oil Refining/Marketing
Misc Health and Biotechnology Services
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
11.7M
20.9M
IPO Year
2023
N/A

Fundamental Metrics

Financial Performance
Metric
BANL
LSTA
Price
$0.41
$1.98
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$23.50
AVG Volume (30 Days)
27.5K
23.1K
Earning Date
09-04-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$580,456,800.00
$1,070,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
11.38
N/A
52 Week Low
$0.40
$1.81
52 Week High
$1.30
$4.20

Technical Indicators

Market Signals
Indicator
BANL
LSTA
Relative Strength Index (RSI) 39.88 35.09
Support Level $0.40 $2.00
Resistance Level $0.46 $2.17
Average True Range (ATR) 0.03 0.11
MACD 0.00 0.00
Stochastic Oscillator 27.41 3.23

Price Performance

Historical Comparison
BANL
LSTA

About BANL CBL International Limited

CBL International Ltd is a marine fuel logistics company that provides a one-stop solution for vessel refueling. In the bunkering industry, it is referred to as a bunkering facilitator. It facilitates vessel refueling between ship operators and local physical distributors/traders by purchasing marine fuel, including fossil fuel and alternative fuel, from its suppliers and arranging for the suppliers to deliver the fuel to the customers. The company's customer base comprises container liners, bulk carriers, and tankers. Geographically, the company generates a majority of its revenue from China, followed by Hong Kong, Malaysia, Singapore, South Korea, and other regions.

About LSTA Lisata Therapeutics Inc.

Lisata Therapeutics Inc is a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product, certepetide, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively. The group has one operating segment, the research and development of its investigational drug product.

Share on Social Networks: